Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.

Biochemical and biophysical research communications - 7 Oct 2016

Wang Ping, Li Ziqiu, Liu Haide, Zhou Dongmei, Fu Aiqin, Zhang Enning

Abstract excerpt

Chemotherapeutic insensitivity is a significant barrier for effective treatment of gastric cancer (GC). Recently, emerging evidence has demonstrated that microRNAs (miRNAs) are critically involved in drug resistance. Here, by a large-scale screen, we noticed low expression of miR-126 in the drug-resistant GC cell lines SGC7901/VCR and SGC7901/ADR compared with their parental cell line SGC7901. Ectopic expression...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 3' Untranslated Regions
Share to Cell Survival

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Doxorubicin

Share to Drug Resistance, Multiple

Share to Drug Resistance, Neoplasm

Share to Enhancer of Zeste Homolog 2 Protein

Share to Stomach Neoplasms

Share to Vincristine

Source

Identifiers

PMID: 27622325
DOI: 10.1016/j.bbrc.2016.09.040

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

MicroRNA-126 increases chemosensitivity in drug-resistant gastric cancer cells by targeting EZH2.PMID 27622325Read ↗

LINC-PINT suppresses cisplatin resistance in gastric cancer by inhibiting autophagy activation via epigenetic silencing of ATG5 by EZH2Semantic proximity Read ↗

GLI2 inhibits cisplatin sensitivity in gastric cancer through DEC1/ZEB1 mediated EMTSemantic proximity Read ↗

miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1Semantic proximity Read ↗

miR-363 promotes proliferation and chemo-resistance of human gastric cancer via targeting of FBW7 ubiquitin ligase expressionSemantic proximity Read ↗

Alteration of gene expression and DNA methylation in drug-resistant gastric cancerSemantic proximity Read ↗

GLI1-mediated regulation of side population is responsible for drug resistance in gastric cancerSemantic proximity Read ↗

miR-107 reverses the multidrug resistance of gastric cancer by targeting the CGA/EGFR/GATA2 positive feedback circuitSemantic proximity Read ↗

Acquisition of a single EZH2 D1 domain mutation confers acquired resistance to EZH2-targeted inhibitors.Semantic proximity Read ↗

Downregulation of Enhancer of Zeste Homolog 2 (EZH2) is essential for the Induction of Autophagy and Apoptosis in Colorectal Cancer CellsSemantic proximity Read ↗

Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cellsSemantic proximity Read ↗

MicroRNA-149 inhibits proliferation and cell cycle progression through the targeting of ZBTB2 in human gastric cancer.Semantic proximity Read ↗

Methylation of miR-129-5p CpG island modulates multi-drug resistance in gastric cancer by targeting ABC transportersSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.